inhibitors of the ribonucleotide reductase of herpes simplex viruses (HSV) potentiate the activity of acyclovir in vitro and in animal studies. In addition, the combination of the ribonucleotide reductase inhibitor 348U87 and acyclovir has synergistic therapeutic effects against infections in mice d
Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis
โ Scribed by Dr. S. L. Spruance
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 572 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recurrent acyclovir (ACV)-resistant (ACV-r) herpes simplex virus type 1 (HSV-1) infections occurred in a patient with Wiskott-Aldrich syndrome, an X-linked recessive immunodeficiency syndrome composed of three clinical characteristics of immunodeficiency, thrombocytopenia, and an eczematous dermatit
Objective: To examine antenatal screening as a predictor of intrapartum shedding of herpes simplex virus (HSV) and to determine its usefulness in guiding the appropriate route of delivery for patients with recurrent HSV in pregnancy. Methods: A population of 198 pregnant women with a history of rec